Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Signs Three New SNP Genotyping Agreements

NEW YORK, Jan 10 – Qiagen Genomics said Wednesday that it has entered into three new licensing agreements involving its Masscode technology for high-throughput SNP genotyping.

The agreements, announced separately, involve Agilent Technologies, Japan’s Daiichi Pharmaceutical subsidiary of Daiichi Pure Chemicals (DPC), and the University of Washington School of Pharmacy.

Under the terms of Qiagen’s exclusive value-added reseller deal with Agilent, both companies agreed to actively promote each other’s technologies in combination. Agilent’s single-quadrupole liquid chromatography/mass spectrometry technology will be used with Qiagen’s Masscode technology to provide SNP genotyping systems that will be marketed by Quiagen.

A second phase of the agreement covers the companies’ joint development of new Masscode tag chemistry and mass spectrometry instrumentation for SNP discovery, proteomics , and other applications.

Under the terms of the agreement with DPC, Qiagen will sell a Masscode system to DPC and will also grant a non-exclusive license related technology that will enable DPC to provide SNP genotyping services to clients in Japan.

The agreement requires that DPC purchase its SNP genotyping chemistry and instrumentation from Qiagen for a five-year period. Qiagen will provide DPC with training and support during the first year of the agreement.

The terms of the agreement with the UW School of Pharmacy cover the school’s purchase of limited, non-exclusive rights to use Masscode for certain specifically defined projects. As part of the agreement, Qiagen obtains the exclusive right to negotiate with UW for exclusive worldwide licenses on any new invention, development, biological material or discovery that results from UW's use of the system.

Financial terms of the three agreements were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.